• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK DUO-VENT SECONDARY MEDICATION SET; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK DUO-VENT SECONDARY MEDICATION SET; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Catalog Number 2C7462
Device Problems Material Integrity Problem (2978); Priming Problem (4040)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Type  malfunction  
Manufacturer Narrative
Should additional relevant information become available, a supplemental report will be submitted.
 
Event Description
It was reported that an unspecified quantity of clearlink system secondary medication sets were causing back-priming issues.This was observed during priming of the secondary sets; however, it was unknown if a patient was involved.There were differences with the connector ports compared to other secondary sets.There was no report of patient injury or medical intervention associated with this event.No additional information is available.
 
Manufacturer Narrative
H10: the actual devices were not available; however, photographs of two devices were provided for evaluation.The photographs showed a set with batch# sr22h23023 with a non vented male luer tip protector while the other set with batch# sr21l17131 had a vented male luer tip protector.Visual inspection of the photographs did not identify any issues with the sets.This product code was updated with a new design (non vented tip protector) in june 2022.The direction instruction on the printed pouch was updated with the new priming method.The cause of the condition could not be determined; however, this was likely related to the user not priming the set with the new priming method after the design change.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK DUO-VENT SECONDARY MEDICATION SET
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - SINGAPORE
2 woodlands industrial park d
singapore 73875 0
SN   738750
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key16268796
MDR Text Key308468866
Report Number1416980-2023-00200
Device Sequence Number1
Product Code FPA
UDI-Device Identifier00085412048475
UDI-Public(01)00085412048475
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K203609
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/07/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/30/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number2C7462
Device Lot NumberSR22H23023
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/06/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-